XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Market Offering [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Market Offering [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Loss [Member]
Market Offering [Member]
Total
Beginning Balance at Dec. 31, 2019   $ 1,508   $ 187,914,916 $ (137,376,122) $ (5,020,156)   $ 45,520,146
Beginning Balance (in shares) at Dec. 31, 2019   15,312,167            
Stock-based compensation       2,576,006       2,576,006
Exercise of stock options   $ 4   128,892       128,896
Exercise of stock options (in shares)   46,966            
Vesting of restricted stock awards including withholding, net   $ 16   (262,729)       (262,713)
Vesting of restricted stock awards including withholding, net (in shares)   84,320            
Issuance of common stock from Employee Stock Purchase Plan   $ 8   135,463       135,471
Issuance of common stock from Employee Stock Purchase Plan (in shares)   92,661            
Issuance of common stock and pre-funded warrants in public offering, net   $ 412   124,027,403       124,027,815
Issuance of common stock and pre-funded warrants in public offering, net (in shares)   4,119,564            
Issuance of common stock in at the market offerings, net $ 560   $ 48,155,512       $ 48,156,072  
Issuance of common stock in at the market offerings, net (in shares) 5,594,455              
Issuance of common stock related to contingent consideration liability   $ 169   13,624,841       13,625,010
Issuance of common stock related to contingent consideration liability (in shares)   1,694,906            
Issuance of common stock upon cashless exercise of warrants   $ 1,020   41,037,438       41,038,458
Issuance of common stock upon cashless exercise of warrants (in shares)   10,197,907            
Unrealized (loss) gain on short-term investments           (24,361)   (24,361)
Net loss         (49,044,477)     (49,044,477)
Ending Balance at Dec. 31, 2020   $ 3,697   417,337,742 (186,420,599) (5,044,517)   225,876,323
Ending Balance (in shares) at Dec. 31, 2020   37,142,946            
Stock-based compensation       5,518,890       5,518,890
Exercise of stock options   $ 6   176,448       $ 176,454
Exercise of stock options (in shares)   54,068           54,068
Vesting of restricted stock awards including withholding, net   $ 4   (400,341)       $ (400,337)
Vesting of restricted stock awards including withholding, net (in shares)   (28,850)            
Issuance of common stock from Employee Stock Purchase Plan   $ 3   224,469       224,472
Issuance of common stock from Employee Stock Purchase Plan (in shares)   24,100            
Retirement of common stock in exchange for common stock warrant   $ (100)   (7,539,900) (9,660,000)     (17,200,000)
Retirement of common stock in exchange for common stock warrant (in Shares)   (1,000,000)            
Issuance Of Common Stock Warrant In Exchange For Retirement Of Common Stock       (17,200,000)       (17,200,000)
Issuance of common stock in at the market offerings, net $ 480   $ 64,814,899       $ 64,815,379  
Issuance of common stock in at the market offerings, net (in shares) 4,800,454              
Issuance of common stock upon cashless exercise of warrants       10,000       10,000
Issuance of common stock upon cashless exercise of warrants (in shares)   1,050            
Unrealized (loss) gain on short-term investments           4,354   4,354
Net loss         (97,090,824)     (97,090,824)
Ending Balance at Dec. 31, 2021   $ 4,090   $ 497,342,207 $ (293,171,423) $ (5,040,163)   $ 199,134,711
Ending Balance (in shares) at Dec. 31, 2021   40,993,768